hcc

Documents about hcc

• Chidamide + Regorafenib in Hepatocellular Carcinoma (HCC)#1231710ClinicalTrials.gov
• Multimodal Thermal Therapy With Targeted and Immunotherapy for Untreated Unresectable HCC#1420509ClinicalTrials.gov
• Biannual Screening for HCC Offered to Patients With Cirrhosis. Introducing Surveillance for Hepatocellular Carcinoma (HCC) in the Central Denmark Region Using Ultrasound and Alpha-Fetoprotein to Reduce HCC-Related Mortality in Patients With Compensated Non-Viral Cirrhosis#1465491ClinicalTrials.gov
• Netrin-1 & Hepatocellular Carcinoma HCC#993001ClinicalTrials.gov
• HCC Patient Preferences in Japan#1373074ClinicalTrials.gov
• AI Multitask Model for HCC Treatment#912903ClinicalTrials.gov
• Streamlining Radioembolization for Small HCC#1376397ClinicalTrials.gov
• Safety and Feasibility of CIK Cell Therapy in HCC After Tumor Resection#869415ClinicalTrials.gov
• Retrospective Clinical Validation of HepatoPredict#850431ClinicalTrials.gov
• Predictive Value of Albumin - Bilirubin Score and CRP - Albumin - Lymphocyte Index for HCC Prognosis After Radical Resection#1259665ClinicalTrials.gov
• A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)#1394528ClinicalTrials.gov
• Neoadjuvant Anti-PD1 in HCC#256898ClinicalTrials.gov
• Lenalidomide Plus Targeted Therapy and Immunotherapy for Refractory HCC#303734ClinicalTrials.gov
• ALBI and PALBI Scores and HCC Prognosis#868854ClinicalTrials.gov
• Same-day Radioembolization for Large HCC#879772ClinicalTrials.gov
• Y90 Radiation Segmentectomy vs SBRT for HCC#966374ClinicalTrials.gov
• Predictors and Outcome of Rupture HCC in AU Hospitals#1338196ClinicalTrials.gov
• Hepatocellular Carcinoma (HCC)_Torisel_#1370627ClinicalTrials.gov
• Statin With Palliative Therapy for HCC#1395958ClinicalTrials.gov
• Hepatectomy for Early-stage HCC Patients With CSPH#1443433ClinicalTrials.gov
• FMT in IT-refractory HCC - FAB-HCC Pilot Study#909968ClinicalTrials.gov
• Study of ET140202 T Cells in Adults With Advanced Hepatocellular Carcinoma#892263ClinicalTrials.gov
• Adjuvant Sintilimab Plus Lenvatinib for HCC Characterized With VETC Following Liver Resection#889656ClinicalTrials.gov
• Mts105 for Advanced Hepatocellular Carcinoma#1377058ClinicalTrials.gov
• RT+ Anti-PD-1 for Patients With Advanced HCC (RT+PD-1-HCC)#1498473ClinicalTrials.gov
• SBRT in HCC With Oligoprogression on First-line Immunotherapy#414492ClinicalTrials.gov
• Predictors of Sorafenib Response in HCC#909578ClinicalTrials.gov
• TACE Plus Ivonescimab for Unresectable Non-Metastatic HCC#1293689ClinicalTrials.gov
• A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer#842478ClinicalTrials.gov
• DNP-MRSI of HCC Metabolism to Predict Therapeutic Response#812606ClinicalTrials.gov
• Predictors of HCC in Post-HCV Cirrhotic Patients After SVR#916089ClinicalTrials.gov
• Study of ET140203 T Cells in Adults With Advanced Hepatocellular Carcinoma (ARYA-1)#1244843ClinicalTrials.gov
• Novel Biomarker Assay for Biomarker Assay for HCC Detection#911914ClinicalTrials.gov
• Individualized Surgical Guidance in HCC-BDTT#992346ClinicalTrials.gov
• A New Conception About Individualized Treatment Allocation for HCC#1213818ClinicalTrials.gov
• HCC Risk Prediction Model Based on Multimodal Data in Chronic Hepatitis B#1032605ClinicalTrials.gov
• Nivolumab Plus Ipilimumab as Neoadjuvant Therapy for Hepatocellular Carcinoma (HCC)#429763ClinicalTrials.gov
• Sequential TACE and SBRT Followed by ImmunoTherapy for Downstaging HCC for Hepatectomy#454042ClinicalTrials.gov
• Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC#842887ClinicalTrials.gov
• The Utility of Breath Biopsy as a Screening Tool for HCC#861064ClinicalTrials.gov
• Sorafenib Dose Ramp-Up in Hepatocellular Carcinoma (HCC)#892110ClinicalTrials.gov
• Combined Treatment of RFA and Sorafenib on Recurrent HCC#1183001ClinicalTrials.gov
• OBT Measurement to Differentiate Between Presence and Absence of HCC Determined by MRI#1485139ClinicalTrials.gov
• Detection of Hepatocellular Carcinoma (HCC) With Octanoate Breath ID Test Compared to MRI#1364447ClinicalTrials.gov
• Sorafenib PK in Patients With Advanced HCC and Child-Pugh B#1376237ClinicalTrials.gov
• SBRT With Immunotherapy and Atezo-Bev in HCC With Major Portal Vein Thrombosis#146433ClinicalTrials.gov
• Therapeutic Effects of Immuno-targeted Therapy Combined With or Without RT for HCC#195308ClinicalTrials.gov
• Lenalidomide to Reverse Drug Resistance After First-line Treatment of Advanced HCC#287539ClinicalTrials.gov
• Combination of Sintilimab and Stereotactic Body Radiotherapy in Advanced Metastatic HCC#432874ClinicalTrials.gov
• Study of Sorafenib With or Without VT-122 in Patients With Hepatocellular Carcinoma (HCC)#842976ClinicalTrials.gov